Taiwan-made enterovirus vaccine clears trial, could hit market soon
04/11/2021 08:28 PM
Taipei, April 11 (CNA) Taiwan-based Medigen Vaccine Biologics Corp. (MVC) on Sunday announced positive trial results for its enterovirus 71 (EV71) virus vaccine and expressed hope the vaccine could hit the market in Taiwan next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Man arrested for growing and selling cannabis, 97 plants seized
03/19/2024 09:39 PM - Science & Tech
Nvidia unveils super chip using TSMC technology at annual conference
03/19/2024 09:35 PM - Society
Magnitude 5.0 earthquake shakes eastern Taiwan
03/19/2024 08:56 PM - Business
AirAsia to launch 3 routes between Taiwan and Japan
03/19/2024 08:33 PM - Politics
Eswatini prime minister reaffirms ties during Tsai meet
03/19/2024 07:47 PM